The global dialysis market size is expected to reach $145.12 billion by 2026 from $97 billion in 2018, registering a CAGR of 5.8% from 2019 to 2026.
The report provides comprehensive analyses of the top winning strategies, industry dynamics, market size & estimations, key market segments, and competitive landscape.
Increase in government funding for dialysis, rise in incidence of hypertension & diabetes, surge in the number of ESRD patients, and dearth of kidney donors drive the growth of the market. However, product recalls and health risks & complications associated with dialysis hamper the growth of the market. On the other hand, technological advancements and growing inclination toward home peritoneal dialysis treatment would create new pathways to the market players in future.
The report analyzes and forecasts the dialysis market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global dialysis market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the dialysis market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of dialysis market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Leading market players
The key market players analyzed in the study are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International, Inc., B. Braun Avitum AG, Nipro Corporation, Nikkiso Co. Ltd., Diaverum Deutschland GmbH., Asahi Kasei Corporation, NxStage Medical, Inc., and Medicators, Inc. These players have implemented various strategies such as partnerships, mergers & acquisitions, expansions, collaborations, joint ventures, and others to gain a stronghold in the market.
Segmentation:
By Type
Hemodialysis
Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis
Peritoneal Dialysis
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
By Products & Services
Equipment
Dialysis Machines
Water Treatment Systems
Others
Consumables
Dialyzers
Catheters
Others
Drugs
Services
By End User
In-center Dialysis
Home Dialysis
By Region
North America
Europe
LAMEA
Asia-Pacific
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Section 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
Section 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Section 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTER’S FIVE FORCES ANALYSIS
3.4. GOVERNMENT REGULATION
3.4.1. U.S. FDA
3.4.2. Europe CE Mark
3.4.3. Ministry of Health, Labor, and Welfare (MHLW)
3.5. REIMBURSEMENT SCENARIO
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.1.1. Increase in funding for improved dialysis products and services
3.6.1.2. Increase in the number of ESRD patients
3.6.1.3. Rise in incidence of diabetes and hypertension
3.6.1.4. Shortage of kidneys for transplantation
3.6.2. Restraints
3.6.2.1. Risks and complications associated with dialysis
3.6.2.2. Product recall
3.6.3. Opportunities
3.6.3.1. Technological Advancements Leading to Better Adoption
3.6.3.2. Rise in the demand for home peritoneal dialysis treatment
3.6.3.3. Untapped Markets in Developing Economies
Section 4 DIALYSIS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HEMODIALYSIS
4.2.1. Market size and forecast
4.2.2. Conventional hemodialysis
4.2.2.1. Market size and forecast
4.2.3. Short daily hemodialysis
4.2.3.1. Market size and forecast
4.2.4. Nocturnal hemodialysis
4.2.4.1. Market size and forecast
4.3. PERITONEAL DIALYSIS
4.3.1. Market size and forecast
4.3.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)
4.3.2.1. Market size and forecast
4.3.3. Automated Peritoneal Dialysis (APD)
4.3.3.1. Market size and forecast
Section 5 DIALYSIS MARKET, BY PRODUCTS AND SERVICES
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. EQUIPMENT
5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. Dialysis Machines
5.2.4.1. Market size and forecast
5.2.5. Water Treatment Systems
5.2.5.1. Market size and forecast
5.2.6. Others dialysis equipment
5.2.6.1. Market size and forecast
5.3. CONSUMABLES
5.3.1. Key market trends
5.3.2. Growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Dialyzers
5.3.4.1. Market size and forecast
5.3.5. Catheters
5.3.5.1. Market size and forecast
5.3.6. Other dialysis consumables
5.3.6.1. Market size and forecast
5.4. DIALYSIS DRUGS
5.4.1. Key market trends
5.4.2. Growth factors and opportunities
5.4.3. Market size and forecast
5.5. SERVICES
5.5.1. Key market trends
5.5.2. Growth factors and opportunities
5.5.3. Market size and forecast
Section 6 DIALYSIS MARKET, BY END-USERS
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. IN-CENTER DIALYSIS
6.2.1. Market size and forecast
6.3. HOME DIALYSIS
6.3.1. Market size and forecast
Section 7 DIALYSIS MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.3.1. U.S.: Market size and forecast
7.2.3.2. Mexico: Market size and forecast
7.2.3.3. Canada: Market size and forecast
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.3.1. Germany: Market size and forecast
7.3.3.2. France: Market size and forecast
7.3.3.3. UK: Market size and forecast
7.3.3.4. Italy: Market size and forecast
7.3.3.5. Spain: Market size and forecast
7.3.3.6. Rest of Europe: Market size and forecast
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.3.1. Japan: Market size and forecast
7.4.3.2. China: Market size and forecast
7.4.3.3. Australia: Market size and forecast
7.4.3.4. India: Market size and forecast
7.4.3.5. South Korea: Market size and forecast
7.4.3.6. Taiwan: Market size and forecast
7.4.3.7. Rest of Asia-Pacific: Market size and forecast
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa: Market size and forecast
7.5.3.3. Saudi Arabia: Market size and forecast
7.5.3.4. Rest of LAMEA: Market size and forecast
Section 8 COMPANY PROFILE
8.1. ASAHI KASEI CORPORATION
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. B. BRAUN MELSUNGEN AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. BAXTER INTERNATIONAL INC.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. DAVITA INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. DIAVERUM DEUTSCHLAND GMBH.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. diaverum: Key strategic moves and developments
8.6. FRESENIUS MEDICAL CARE AG & CO.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. MEDIVATORS, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.8. NIKKISO CO. LTD.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. NIPRO CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. NXSTAGE MEDICAL, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments